American Well (NYSE:AMWL) Releases Quarterly Earnings Results, Misses Estimates By $0.07 EPS

American Well (NYSE:AMWL) issued its quarterly earnings data on Wednesday. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.07), Zacks reports. American Well had a negative net margin of 260.63% and a negative return on equity of 40.19%. The business had revenue of $59.52 million for the quarter, compared to analyst estimates of $61.10 million. During the same quarter last year, the business earned ($0.24) EPS. American Well updated its FY 2025 guidance to EPS and its FY 2024 guidance to EPS.

American Well Trading Down 9.3 %

American Well stock traded down $0.05 during mid-day trading on Thursday, reaching $0.48. The company’s stock had a trading volume of 1,884,518 shares, compared to its average volume of 1,979,446. The firm has a market cap of $139.42 million, a price-to-earnings ratio of -0.21 and a beta of 1.12. American Well has a twelve month low of $0.45 and a twelve month high of $2.74. The business has a 50 day moving average price of $0.80 and a 200-day moving average price of $1.07.

Wall Street Analysts Forecast Growth

AMWL has been the topic of several recent analyst reports. Morgan Stanley cut their price target on shares of American Well from $1.75 to $1.00 and set an “equal weight” rating on the stock in a report on Monday, April 15th. Needham & Company LLC restated a “hold” rating on shares of American Well in a research note on Thursday.

Insider Transactions at American Well

In other American Well news, CFO Robert Shepardson sold 319,214 shares of American Well stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total value of $347,943.26. Following the completion of the transaction, the chief financial officer now directly owns 2,845,148 shares in the company, valued at $3,101,211.32. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CFO Robert Shepardson sold 319,214 shares of American Well stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $1.09, for a total value of $347,943.26. Following the sale, the chief financial officer now directly owns 2,845,148 shares in the company, valued at approximately $3,101,211.32. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Vukasin Paunovich sold 251,323 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $273,942.07. Following the completion of the transaction, the executive vice president now owns 2,535,635 shares of the company’s stock, valued at approximately $2,763,842.15. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,158,186 shares of company stock worth $1,255,582. 12.94% of the stock is currently owned by insiders.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.